A double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescents

Journal of Child and Adolescent Psychopharmacology

Volumn 24, Issue 6, 2014, Pages 311-317

  DelBello, Melissa P ^a   Hochadel, Thomas J ^b   Portland, Kimberly Blanchard ^c   Azzaro, Albert J ^b   Katic, Alain ^d   Khan, Arif ^e,f   Emslie, Graham ^g  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Cognitive Research Corporation ^*  (Russian Federation)

^c Mylan Specialty LP   (United States)

^d Clinical Trials Program   (United States)

^e Northwest Clinical Research Center   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SELEGILINE; ANTIDEPRESSANT AGENT;

ABDOMINAL PAIN; ADOLESCENT; AGITATION; ANXIETY; APPLICATION SITE REACTION; ARTICLE; BACKACHE; BRADYCARDIA; CHILD; CHILDREN DEPRESSION RATING SCALE REVISED; CLINICAL GLOBAL IMPRESSION SCALE; COLD SWEAT; CONTROLLED STUDY; DECREASED APPETITE; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DSM-IV; ELECTROCARDIOGRAM; FATIGUE; FEVER; HEADACHE; HEART PALPITATION; HUMAN; INFECTION; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENTAL DISEASE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; NEUROLOGIC DISEASE; NUTRITIONAL DISORDER; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SIDE EFFECT; SOMNOLENCE; SORE THROAT; SUICIDAL IDEATION; TACHYCARDIA; THORAX PAIN; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VITAL SIGN; VOMITING; DEPRESSIVE DISORDER, MAJOR; FEMALE; INTRADERMAL DRUG ADMINISTRATION; MALE; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ANTIDEPRESSIVE AGENTS; CHILD; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; SELEGILINE; SEVERITY OF ILLNESS INDEX; TRANSDERMAL PATCH; TREATMENT OUTCOME;

EID: 84906562313     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2013.0138     Document Type: Article

References (32)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision. Washington, DC: American Psychiatric Association; 2000.
2. Amsterdam JD: A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder. J Clin Psychiatry 64: 208-214, 2003.
3. Amsterdam JD, Bodkin JA: Selegiline transdermal system in the prevention of relapse of major depressive disorder: A 52-week double-blind, placebo-substitution, parallel-group clinical trial. J Clin Psychopharmacol 26: 579-586, 2006.
4. Azzaro AJ, Van Den Berg CM, Blob LF, Kemper EM, Sharoky M, Oren DA, Campbell BJ: Tyramine pressor sensitivity during treatment with selegiline transdermal system 6mg/24hrs in healthy subjects. J Clin Pharmacol 46: 933-944, 2006.
5. Biederman J, Faraone S, Mick E, Lelon E: Psychiatric comorbidity among referred juveniles with major depression: Fact or artifact? J Am Acad Child Adolesc Psychiatry 34: 579-590, 1995.
6. Blackwell B, Marley E, Price J, Taylor D: Hypertensive interactions between monoamine oxidase inhibitors and foodstuffs. Br J Psychiatry 113: 349-365, 1967.
7. Bodkin JA, Amsterdam JD: Transdermal selegiline in major depression: a double-blind, placebo-controlled, parallel-group study in outpatients. Am J Psychiatry 159: 1869-1875, 2002.
8. Bostic JQ, Rubin DH, Prince J, Schlozman S: Treatment of depression in children and adolescents. J Psychiatr Pract 11: 141-154, 2005.
9. Braconnier A, LeCoent R, Cohen D: Paroxetine versus clomipramine in adolescents with severemajor depression: A double-blind, randomized, multicenter trial. J Am Acad Child Adolesc Psychiatry 42: 22-29, 2003.
10. Bridge JA, Birmaher B, Lyengar S, Barbe RP, Brent DA: Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry 166: 42-49, 2009.
11. Casper RC, Redmond DE, Katz MM, Schaffer CB, Davis JM, Koslow SH: Somatic symptoms in primary affective disorder: Presence and relationship to the classification of depression. Arch Gen Psychiatry 42: 1098-1104, 1985.
12. Charney DS, Nemeroff CB, Lewis L, Laden SK, Gorman JM, Laska EM, Borenstein M, Bowden CL, Caplan A, Emslie GJ, Evans DL, Geller B, Grabowski LE, Herson J, Kalin NH, Keck PE Jr, Kirsch I, Kirshnan KR, Kupfer DL, Makuch RW, Miller FG, Pardes H, Post R, Reynolds MM, Roberts L, Rosenbaum JF, Rosenstein DL, Rubinow DR, Rush AJ, Ryan ND, Sachs GS, Schatzberg AF, Soloman S: Consensus development panel: National depressive and manic-depressive association consensus statement on the use of placebo in clinical trails of mood disorder. Gen Arch Psychiatry 59: 262-270, 2002.
13. Emslie GJ, Heiligenstein JH, Wagner KD, Hoog SI, Ernest DE, Brown E, Nilsson M, Jacobson JG: Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. J Amer Acad Child Adolesc Psychiatry 41: 1205-1215, 2002.
14. Emslie GJ, Rush AJ, Weinberd WA, Kowatch RA, Hughes CW, Carmody T, Rintelmann J: A double-blind, randomized, placebocontrolled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54: 1031-1037, 1997.
15. Feiger AD, Rickels K, Moira RA, Zimbroff DL, Robinson DS: Selegiline transdermal system for the treatment of major depressive disorder: an8-week, double-blind, placebo-controlled, flexible-dose titration study. J Clin Psychiatry 67: 1354-1361, 2006.
16. Findling RL, Reed MD, Blumer JL: Pharmacological treatment of depression in children and adolescents. Paediatr Drugs 1: 161-182, 1999.
17. Fleming JE, Offord DR: Epidemiology of childhood depressive disorders: a critical review. J Am Acad Child Adolesc Psychiatry 29: 571-580, 1990.
18. Hazell P: Depression in children and adolescents. Clin Evid (online) 2009: 1008-1039, 2009.
19. Hazell P, O'Connell D, Heathcote D, Robertson J, Henry D: Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ 310: 897-901, 1995.
20. Hill RM, Castellanos D, Petit JW. 2011. Suicide-related behaviors and anxiety in children and adolescencents: A review. Clin Psychol Rev 31: 1133-1144, 1995.
21. Kaminski KM, Naylor MW, King CA, Ghaziuddin N: Reactive mood and atypical depression in psychiatrically hospitalized adolescents. Depression 3: 176-181, 1995.
22. Khan A, Dager SR, Cohen S, Avery DH, Scherzo B, Dunner DL: Chronicity of depressive episodes in relation to antidepressant placebo response. Neuropsychopharmacol 4: 125-130, 1991.
23. Kirsch I, Deacon BJ, Huedo-Medina TB, Moore TJ, Johnson BT: Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. Plos Med 5: e45, 2008.
24. March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S: Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for adolescents with depression study (TADS) randomized controlled trial. J Am Med Assoc 292: 807-820, 2004.
25. Nierenberg AA, Alpert JE, Pava J, Rosenbaum JF, Fava M: Course and treatment of atypical depression. J Clin Psychiatry 59: 5-9, 1998.
26. Posternak MA, Zimmerman M: Therapeutic effects of follow-up assessments on antidepressant and placebo response rates in antidepressant efficacy trials; meta-analysis. Br J Psychiatry 190: 287-292, 2007.
27. Robinson DS: Monoamine oxidase inhibitors: A new generation. Psychopharmacol Bull 36: 124-138, 2002.
28. Stahl SM: Basic psychopharmacology of antidepressants: Pt 1: antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 59 (Suppl 4): 5-14, 1998.
29. Stein DJ, Baldwin DS, Bolberg OT, Despiegel N, Bandelow B: Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram. J Clin Psychiatry 67: 1741-1746, 2006.
30. Thase ME, Trivedi, MH, Rush, AJ: MAOIs in contemporary treatment of depression. Neuropsychopharmacol 12: 185-219, 1995.
31. Weller EB, Weller RA: Treatment options in the management of adolescent depression. J Affective Disord 61: S23-S28, 2000.
32. Wilcox CS, Cohn JB, Linden RD, Heiser JF, Lucas PB, Morgan DL, De Francisco D: Predictors of placebo response: A retrospective analysis. Psychopharmacol Bull 28: 157-162, 1992.